Skip to main content
VCYT logo

Veracyte, Inc.

VCYTNASDAQHealthcareDiagnostics & Research

$43.12Today:- (-)1Y +23.89%

As of Oct 16, 2026 close

Market cap
$3.64B
P/E (TTM)
31.82
Forward P/E
15.73
Dividend yield
-
52-week range
$29.46$60.91
Volume (live)
-
Avg. volume (3M)
1.41M

Veracyte (VCYT) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Veracyte had a P/E ratio of 50.16 (down from 127.14), return on equity of 5.3% (up from 2.2%), debt-to-equity of 0.03 (down from 0.04) and a current ratio of 8.15 (up from 4.73). A current ratio of 8.15 means current assets exceed current liabilities.

Veracyte Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio50.16127.14----
Forward P/E27.0843.53----
P/S Ratio6.436.885.575.7413.3324.12
P/B Ratio2.542.611.921.582.676.73
Price/Tangible Book7.349.367.968.3315.757.90
Price/FCF26.2848.1058.65---
Price/OCF24.4140.8745.44225.97--
PEG Ratio0.731.24----
Enterprise Value Ratios
EV/Revenue5.806.315.045.2312.6521.29
EV/EBITDA35.5762.36417.68---
EV/EBIT47.66129.85----
EV/FCF23.7144.1153.14---
Profitability & Returns
Return on Equity (ROE)5.34%2.17%-7.02%-3.37%-9.96%-10.57%
Return on Assets (ROA)2.91%1.12%-1.26%-2.00%-6.16%-5.60%
Return on Invested Capital (ROIC)6.54%2.29%-2.61%-4.06%-15.85%-36.86%
Return on Capital Employed (ROCE)4.70%1.80%-2.20%-3.40%-7.20%-7.40%
Leverage & Solvency Ratios
Debt/Equity0.030.040.010.010.020.03
Debt/EBITDA0.380.821.31---
Debt/FCF0.310.800.37---
Liquidity Ratios
Current Ratio8.154.734.663.973.7922.39
Quick Ratio7.634.274.193.563.4121.92
Efficiency Ratios
Asset Turnover0.380.370.320.250.270.32
Inventory Turnover6.817.187.427.969.377.04
Yield & Distribution Ratios
Earnings Yield1.99%0.79%-3.70%-2.15%-2.58%-1.23%
FCF Yield3.81%2.08%1.71%-0.06%-1.26%-0.44%
Buyback Yield-3.08%-7.60%-1.53%-5.39%-27.52%-15.39%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Veracyte Financial Ratios

What is Veracyte's P/E ratio?

Veracyte's P/E ratio was 50.16 for fiscal 2025 (period ended Dec 31, 2025). It was 127.14 a year earlier.

What is Veracyte's return on equity?

Veracyte's return on equity (ROE) was 5.3% for fiscal 2025 (period ended Dec 31, 2025). It was 2.2% a year earlier.

What is Veracyte's debt-to-equity ratio?

Veracyte's debt-to-equity ratio was 0.03 for fiscal 2025 (period ended Dec 31, 2025). It was 0.04 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition